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Abstract
Introduction: The aim of this paper is to present results of first two years of preanalytical external quality assessment (EQA) in Croatia.
Materials and methods: This paper summarizes results from 6 rounds of preanalytical EQA during 2014-2016 in 161-175 Croatian laboratories 
(number ranged between cycles). EQA was designed as an online survey of the compliance with National recommendations for phlebotomy (NRP). 
Forty-seven questions in 5 categories are analyzed (materials and equipment, patient identification, patient preparation, sampling and storage). 
Additionally, preanalytical cases are presented. Overall performance scores (Question score (Qscore) for compliance with NRP and Case score (Cscore) 
for preanalytical cases) are calculated for each question/case as a proportion of laboratories with satisfactory procedure (x 100). Qscores and Cscores 
≥ 70 were classified as acceptable (maximal score = 100).
Results: In investigation of compliance with NRP, acceptable Qscores were obtained for 34/47 questions. The lowest scores were observed for the 
availability of sterile disposable tourniquets (Qscore = 15) and safe-sharp needles (Qscore = 34), obtaining patients address as an identifier (Qsco-
re = 21), using glycolysis inhibitor tubes for glucose concentration measurement (Qscore = 21) and verification of manufacturers declarations on 
temperature and time of storage (Qscore = 31). There was no statistically significant difference in overall Qscore according to different categories of 
phlebotomy procedures (P = 0.284). The results of preanalytical cases showed acceptable Cscore values for all cases (89-96).
Conclusion: First two years of preanalytical EQA showed good compliance with the NRP and excellent expertise in resolving complex preanalytical 
issues. Major critical spots are lack of availability of safe-sharp needles, disposable tourniquets and glucose inhibitor tubes.
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Introduction
External quality assessment (EQA) of the analytical 
phase of laboratory work has, for some time, been 
established as an essential tool for quality assur-
ance. Many different providers available at the 
market ensure that laboratories can choose the 
schemes that best meet their needs regarding the 
cost, sample quality, time of delivery or quality of 
reports. The ISO 15189:2012 states that “External 
quality assessment programs should, as far as pos-
sible, provide clinically relevant challenges that 
mimic patient samples and have the effect of 
checking the entire examination process, includ-
ing pre- and post-examination procedures” (1). 
Laboratories should, therefore, additionally partic-
ipate in EQAs that cover extra-analytical phase of 
laboratory work.
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According to Kristensen GB et al., there are three 
main types of preanalytical EQA (2). Type I refers to 
registration of procedures. This type includes 
questionnaires where participants are asked to de-
clare their practices regarding certain aspects of 
preanalytical phase. Even though the most simple 
to organize, Type I preanalytical EQA still provides 
valuable information on management of preana-
lytical phase in laboratories (2). In Type II, samples 
with preanalytical errors (e.g. hemolysis, lipemia, 
icterus) are sent to laboratories for processing. This 
type of EQA can be costly and production of ade-
quate materials can be analytically challenging. In 
Type III EQA, preanalytical errors or quality indica-
tors are continuously monitored and recorded into 
databases (3,4). However, in order to obtain valua-
ble information from this data, participating labo-
ratories need to regularly record preanalytical er-
rors during their routine work. Also, definition of 
particular preanalytical errors can differ between 
laboratories. 
The first efforts in recording the state of manage-
ment of extra-analytical phase in Croatia was done 
in 2009 (5). This study discovered unacceptably 
low awareness of the importance of preanalytical 
phase, especially regarding phlebotomy proce-
dures. Similar results were conformed on a wider 
level in a subsequent multicentre investigation of 
the quality of the extra-analytical phase of labora-
tory practice in some developing European coun-
tries and Mexico (6). These alarming results moti-
vated Croatian Society of Medical Biochemistry 
and Laboratory Medicine to form a Working group 
for the preanalytical phase (WGPA CSMBLM) in 
2012, and implement preanalytical External Quali-
ty Assessment in Croatian Centre for Quality As-
sessment in Laboratory Medicine (CROQALM) in 
2014. Up to now, only Type I preanalytical EQA has 
been conducted. As a first step in improving phle-
botomy procedures, National recommendations 
for venous blood sampling were issued (7). The 
main goal of preanalytical EQA was to get the 
overview of the quality of policies and procedures 
in Croatian laboratories, identify room for im-
provement and encourage harmonization of pre-
analytical practices. 
The aim of this paper is, by presenting data col-
lected by two-year preanalytical EQA, to assess the 
i) level of compliance to the National recommen-
dations for phlebotomy (NRP) (7); ii) level of exper-
tise in resolving complex preanalytical issues pre-
sented in preanalytical cases. Moreover, we aimed 
to identify, otherwise overlooked, most critical 
steps in the preanalytical phase on a national level.
Materials and methods
CROQALM is the Croatian External quality provider 
offering different analytical modules for various 
fields of laboratory diagnostics (general and spe-
cific clinical chemistry, haematology and coagula-
tion, cardiac markers, urinalysis, blood gas testing, 
immunochemistry and HbA1c). Each module has 
appointed module coordinator, who is responsible 
for the general strategy of the specific EQA, includ-
ing data analysis and interpretation. In September 
2014, CROQALM introduced two new extra-analyt-
ical modules in the EQA scheme: preanalytical and 
postanalytical module. During the 2014, only one 
cycle of the preanalytical EQA was conducted. This 
cycle included 3 preanalytical cases from the rou-
tine practice. From the year 2015, preanalytical 
scheme is conducted three times a year. All three 
cycles in the 2015 and the first cycle in the 2016 in-
cluded questionnaire about the compliance with 
the National recommendations for venous blood 
sampling (7). The second cycle in the 2016 again 
included 3 preanalytical cases. This paper summa-
rizes results of these first six cycles up to June 2016.
Invitation for participation in the preanalytical 
EQA module is sent out to all Croatian laboratories. 
Total number of invited laboratories varied slightly 
across the time (in 2014: N = 180; for three cycles in 
2015: N = 194, 192 and 191, respectively; for two cy-
cles in 2016: N = 198). 
Participation in the scheme is free of charge for all 
Croatian laboratories. For other analytical EQA 
modules in CROQALM, acceptance criterion for 
each parameter is set and based on the laboratory 
performance; percentage of agreement is calculat-
ed by the module coordinator. For the preanalyti-
cal module, answers of the participants are not 
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scored. Answers that differed from the expected 
answers were not recorded as errors. Data analy-
ses and explanations are provided for educational 
purposes only. 
Preanalytical modules are conducted using web 
service and software for CROQALM (inlab2*QALM, 
In2 group, Croatia). Head of each laboratory (or 
person responsible for the EQA within laboratory) 
has unique username and password for accessing 
questions and entering results. Opening of the cy-
cle is announced via e-mail notification. Upon ini-
tiation of the cycle, cases or questions are available 
in the web based software inlab2*QALM. Within 15 
days upon opening, laboratory heads are required 
to submit answers which reflect procedures con-
ducted in their laboratories. After completion of 
the cycle, participants’ answers and data on par-
ticipating laboratory types are exported from the 
database and analysed by the preanalytical mod-
ule coordinator. 
Questionnaire
Four cycles of the preanalytical EQA were de-
signed to investigate compliance with procedures 
described in the National recommendations for 
venous blood sampling (7). Each cycle covered 
one area of the phlebotomy procedure: a) materi-
als and equipment, b) patient identification, c) pa-
tient preparation, d) sampling and e) storage (pa-
tient preparation and sampling were addressed in 
the same cycle). Total of 47 questions is included. 
Participants were asked to report if the procedures 
were implemented in their laboratories by closed 
questions with one of following answers: yes, no 
or sometimes. All questions were formulated in a 
way that answer “yes” is a desirable answer. “Non 
applicable” option was also available.
Preanalytical cases were distributed across two cy-
cles. Four possible answers were available for each 
case. Participants were asked to choose answer 
which best describes their laboratory procedure in 
the presented case.
Statistical analysis
Individual data are presented as counts and per-
centages. 
In order to compare overall participants perfor-
mance on specific questions in the part of the 
questionnaire that investigated compliance with 
the recommendations, Question score (Qscore) 
was created. Numerical value is attributed to each 
possible answer: “yes” – 2 points, “sometimes” – 1 
point and “no” – 0 points. Answers “non applica-
ble” were excluded from the analysis. Since there 
was unequal number of participants among cy-
cles, a maximum score was calculated for each 
question (as if all participants answered “yes”; 
number of participants x 2). Then, actual partici-
pants’ answers were summarized according to for-
mula:
Participants score = (number of “yes” answers x 2) 
+ (number of “sometimes” answers x 1). 
Qscore was presented as a whole number and cal-
culated according to formula:
Qscore = (participants score / maximum score) x 
100.
For the comparison of participants performance in 
preanalytical case studies, Case score (Cscore) was 
calculated. Numerical value is attributed to each 
possible answer: from 0 to 5 points. Numerical val-
ues were assessed by the module coordinator. 5 
points was attributed to the most desirable proce-
dure regarding the case, 0 points was attributed to 
the most erroneous procedure; points in between 
were attributed to acceptable procedures based 
on the level of deviation from the most desirable 
procedure. Since there was unequal number of 
participants among cycles, a maximum score was 
calculated for each case study (as if all participants 
chose the most desirable procedure, number of 
participants x 5). Then, actual participants’ an-
swers were summarized according to formula:
Participants score = (number of “5 point” answers 
x 5) + (number of “4 point” answers x 4) + etc.
Cscore was presented as a whole number and cal-
culated according to formula:
Cscore = (participants score / maximum score) x 
100.
Qscores and Cscores ≥ 70 were classified as ac-
ceptable.
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Difference in overall Qscore according to different 
categories of phlebotomy procedures: 1) materials 
and equipment, 2) patient identification, 3) patient 
preparation and sampling (these categories were 
combined due to the small number of questions in 
the patient preparation category) and 4) transpor-
tation and storage was tested using Kruskal Wallis 
test. P values < 0.05 were considered statistically 
significant.
Statistical analysis was done using Microsoft Excel 
(version 2010, Microsoft, USA) and MedCalc (Med-
Calc Software, version 11.5.1.0, Ostend, Belgium).
Results
Number of participating laboratories, response 
rate and distribution of types of laboratory are 
presented in Table 1. Response rate was high and 
ranged from 84.8% to 90.2%.
Table 2 presents summary of results to the self-re-
porting part of the questionnaire regarding com-
pliance with procedures described in the National 
recommendations for venous blood sampling (7).
Overall, acceptable Qscores were obtained for 
34/47 items included into questionnaire investi-
gating compliance with the venous blood sam-
pling procedures described in the National recom-
mendations. However, there were some proce-
dures with unexpectedly low compliance. The 
lowest scores were observed for the availability of 
sterile disposable tourniquets (#9, Qscore = 15) 
and safe-sharp needles (#4, Qscore = 34) in the cat-
egory equipment, obtaining patients address as 
an identifier in category identification (#15, Qscore 
= 21), using exclusively tubes with glycolysis inhibi-
tor for glucose concentration measurement (#40, 
Qscore = 21) and verification of manufacturers 
declarations on temperature and time of storage 
(#47, Qscore = 31) in the category transport and 
storage. Almost complete compliance (Qscores > 
98) was recorded for repeating unsuccessful phle-
botomy at different puncture site (#30), following 
manufacturer’s declarations on temperature and 
time of storage of samples (#46), measuring coag-
ulation tests within 4 hours from sampling (#44), 
monitoring allowed time from sampling to meas-
urement for urinalysis (#43) and marking tubes 
with laboratory ID number (#19).
There was no statistically significant difference in 
overall Qscore according to different categories of 
phlebotomy procedures (P = 0.284) (Figure 1).













Primary healthcare laboratories 81 (50.3%) 90 (51.4%) 85 (50.3%) 85 (50.6%) 85 (50.0%) 85 (50.6%)
Hospital laboratories 80 (49.7%) 85 (48.6%) 84 (49.7%) 83 (49.4%) 85 (50.0%) 83 83 (49.4%)
General hospital 17 (10.6%) 18 (10.3%) 17 (10.1%) 17 (10.1%) 18 (10.6%) 17 (10.1%)
County hospital 6 (3.7%) 6 (3.4%) 6 (3.6%) 5 (3.0%) 6 (3.5%) 6 (3.6%)
University and specialized 
hospitals 20 (12.4%) 22 (12.6%) 22 (13.0%) 23 (13.7%) 23 (13.5%) 23 (13.7%)
University hospital centres 10 (6.2%) 11 (6.3%) 11 (6.5%) 10 (6.0%) 10 (5.9%) 9 (5.4%)
Specialized polyclinic 3 (1.9%) 4 (2.3%) 4 (2.4%) 4 (2.4%) 3 (1.8%) 4 (2.4%)
Private polyclinic 22 (13.7%) 24 (13.7%) 24 (14.2%) 24 (14.3%) 25 (14.7%) 24 (14.3%)
Total number of participating 
laboratories 161 175 169 168 170 168
Total number of invited 
laboratories 180 194 192 191 198 198
Response rate 89.4% 90.2% 88.0% 88.0% 85.8% 84.8%
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Table 2. Self-reporting answers regarding compliance to the National recommendations for venous blood sampling in CROQALM 
EQA.
# Question Y (N) N (N) S (N) Qscore
Materials and equipment
1 Written instruction for blood sampling is available at the phlebotomy station. 163 10 1 94
2 Different diameter needles are available at the phlebotomy station. 153 14 7 90
3 Butterfly needles are available at the phlebotomy station. 120 36 17 74
4 Safe-sharp needles are available at the phlebotomy station. 48 105 20 34
5 Different volume tubes are available at the phlebotomy station. 132 29 13 80
6 Sterile pads for disinfection of the puncture site are available at the phlebotomy station. 94 71 8 57
7 Sterile disposable gloves are available at the phlebotomy station. 134 34 3 79
8 Sterile disposable holders are available at the phlebotomy station. 75 86 11 47
9 Sterile disposable tourniquets are available at the phlebotomy station. 22 144 7 15
10 Professional phlebotomy chair is available at the phlebotomy station. 79 2 91 72
11 Disposable containers are available at the phlebotomy station. 154 13 5 91
Patient identification
12 Patient has to provide identification document prior to blood sampling. 71 64 34 52
13 Prior to blood sampling, phlebotomist asks the patient to identify himself. 159 3 6 96
14 Prior to blood sampling, phlebotomist asks the patient about the date of birth. 93 26 49 70
15 Prior to blood sampling, phlebotomist asks the patient about the address. 13 109 45 21
16 All tubes are labeled with barcode. 98 66 1 60
17 Patient’s name is present on each tube. 148 13 8 90
18 Patient’s date of birth is present on each tube. 68 60 39 52
19 Laboratory ID number is present on each tube. 164 4 0 98
20 At least two identifiers are present on each tube. 141 20 7 86
21 Tubes are labeled prior to blood sampling. 152 13 4 91
22 The name of phlebotomist is recorded for every tube. 108 42 18 70
23 Time of sampling is recorded for every tube. 125 25 17 80
Patient preparation
24 Fasting status is checked prior to sampling. 147 5 15 93
25 If the patient is not fasting, phlebotomy is postponed. 149 3 15 94
Sampling
26 Tourniquet is always used during the sampling. 130 32 6 79
27 Phlebotomist puts on gloves before applying tourniquet. 144 8 16 90
28 In order to avoid hemolysis and burning sensation, phlebotomist waits for disinfectant to evaporate before the puncture. 145 19 4 88
29 Evacuated tubes are not used when Sampling has to be repeated due to problems during phlebotomy (insufficient blood flow). 52 60 56 48
30 Sampling is repeated at different puncture site when the first phlebotomy was unsuccessful. 166 0 2 99
31 Tourniquet is released when blood starts to flow into first tube. 142 11 15 89
32 Tubes are mixed immediately after phlebotomy, before the needle is removed from the vein. 133 29 6 81
33 Coagulation tube is drawn before the serum tube. 142 20 5 87
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# Question Y (N) N (N) S (N) Qscore
Transport and storage
34 Laboratory monitors time from phlebotomy to sample admission for tubes sampled outside of laboratory. 118 27 / 81
35 Laboratory monitors temperature conditions for tubes sampled outside of laboratory. 102 36 / 74
36 Laboratory has written procedures for delivering samples by postal services. 39 34 / 53
37 Laboratory has criteria for rejecting samples due to nonconformities during delivery. 112 35 / 76
38 Only samples delivered on ice are accepted for ammonia concentration measurement. 34 3 / 92
39 Only samples delivered on ice are accepted for lactate concentration measurement. 26 9 / 74
40 Only tubes with glycolysis inhibitor are accepted for glucose concentration measurement. 30 112 / 21
41 For adrenocorticotropic hormone (ACTH) measurement, blood is sampled in cooled tubes and immediately placed on ice. 24 7 / 77
42 Laboratory declares maximal allowed time from sampling to analysis for blood gas testing and rejects samples that are not fulfilling criteria. 43 7 / 86
43 Laboratory declares maximal allowed time from sampling to analysis for urinalysis and rejects samples that are not fulfilling criteria. 157 4 / 98
44 All coagulation tests are done within 4 hours from sampling. 152 3 / 98
45 Laboratory collects and stores sampled for the longer period of time for certain tests (tests are not done immediately). 70 96 / 42
46 Laboratory follows manufacturer’s declarations on temperature and time of storage. 151 2 / 99
47 Laboratory has verified manufacturer’s declarations on temperature and time of storage. 46 102 / 31
























P  = 0.284
Figure 1. Qscore according to different categories of phleboto-
my procedure. 
Individual data are presented with white circles, median value 
is presented with black square, 95% confidence interval of the 
median is presented with grey line.
Results of the 6 preanalytical cases are presented 
in Tables 3 to 8. In all cases, calculated Cscores ac-
ceptable and ranged from 89 to 96. 
Case 1 was presented as follows: Patient arrives 
to laboratory with 24-hour urine for creatinine 
clearance testing. Urine is collected into clean 
plastic bottle (volume 1.5 litres) and the bottle is 
completely filled. After confirming collection 
technique with the laboratory staff, patient ad-
mits that one small part of the first morning 
urine on the second day (by patient’s estimation 
1 to 2 dL) was discarded because the collection 
bottle was already completely filled. Please se-
lect answer which best describes laboratory 
procedure in the presented case.
Results, available answers and overall case score 
are presented in Table 3. Overall case score was 94. 
Neither laboratory chose the least desirable proce-
dure.
Case 2 was presented as follows: Patient arrives 
to laboratory at 11 am with a request for the oral 
glucose tolerance test (oGTT). The patient is still 
fasting and has not consumed any food and 
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drink. Please select answer which best describes 
laboratory procedure in the presented case.
Case 1 N = 151 Points Max case points
Case 
points Cscore
1. the sample is accepted for testing, the result is reported without any 
comments 0 0
755 713 94
2. although the sample is inadequate it is accepted for testing, but the result 
is reported with an interpretative comment 9 3
3. the sample is inadequate and is not accepted for testing 136 5
4. although the sample is inadequate, in exceptional situations may be 
accepted if the patient or ordering physician explicitly require it 6 1
Table 3. Preanalytical cases in CROQALM EQA: results, available answers and overall case score for Case 1.
Case 2 N = 160 Points Max case points
Case 
points Cscore
1. the sample is accepted for testing, the result is reported without any 
comments 4 0
800 712 89
2. although the sample is inadequate it is accepted for testing, but the result 
is reported with an interpretative comment 10 3
3. the sample is inadequate and is not accepted for testing 134 5
4. although the sample is inadequate, in exceptional situations may be 
accepted if the patient or ordering physician explicitly require it 12 1
Table 4. Preanalytical cases in CROQALM EQA: results, available answers and overall case score for Case 2.
Figure 2. Coloured scale accompanying the preanalytical Case 3.
Test tubes No .
Free Hemoglobin (g/L)
Results, available answers and overall case score 
are presented in Table 4. The lowest overall case 
score was recorded for this case (Cscore = 89). 4 
out of 160 laboratories chose the least desirable 
procedure.
Case 3 was presented as follows: The laboratory 
has received the serum sample with a request 
for potassium measurement. The sample is 
slightly haemolysed (free haemoglobin concen-
tration of 0.5 g/L; Figure 2: tube No. 3). Please se-
lect answer which best describes laboratory 
procedure in the presented case.
Results, available answers and overall case score 
are presented in Table 5. Overall case score was 92. 
Neither laboratory chose the least desirable proce-
dure.
Case 4 was presented as follows: An outpatient 
sample for prothrombin time (PT) measurement 
is delivered to laboratory. The tube was sam-
pled in the patient’s home by medical staff and 
delivered to laboratory by courier service. The 
service is not covered by insurance; patient is 
paying for his laboratory testing. The citrate 
tube is not completely filled; plasma level is 0.5 
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Case 3 N = 159 Points Max case points
Case 
points Cscore
1. the sample is accepted for testing, the result is reported without any 
comments 0 0
795 733 92
2. although the sample is inadequate it is accepted for testing, but the result 
is reported with an interpretative comment 15 3
3. the sample is inadequate and is not accepted for testing 136 5
4. although the sample is inadequate, in exceptional situations may be 
accepted if the patient or ordering physician explicitly require it 8 1
Table 5. Preanalytical cases in CROQALM EQA: results, available answers and overall case score for Case 3.
cm below the lower acceptable mark. Please se-
lect answer which best describes laboratory 
procedure in the presented case.
score, the same as in Case 2 was recorded for this 
case (Cscore = 89). 1 out of 165 laboratories chose 
the least desirable procedure.
Case 4 N = 168 Points Max case points
Case 
points Cscore
1. the sample is inadequate and is not accepted for testing 142 5
840 769 92
2. the sample is accepted for testing, PT result is reported with an 
accompanying comment on insufficient plasma volume 18 3
3. the sample is accepted for testing, PT result is reported without any 
accompanying comments 3 0
4. although the sample is inadequate, since it was delivered from patients 
home, in this exceptional situation sample will be accepted for PT testing 
(hospital samples with insufficient volume are rejected)
5 1
Table 6. Preanalytical cases in CROQALM EQA: results, available answers and overall case score for Case 4.
Results, available answers and overall case scores 
are presented in Table 6. Overall case score was 92. 
3 out of 168 laboratories chose the least desirable 
procedure.
Case 5 was presented as follows: Laboratory re-
ceives samples from the general physician offic-
es in the area. Due to the problems with the de-
livery, a sample drawn at 8 am is delivered to 
laboratory at 1 pm. Blood is collected into se-
rum tube with clot activator without gel. C-reac-
tive protein (CRP) and glucose are ordered. 
Please select answer which best describes labo-
ratory procedure in the presented case.
Case 6 was presented as follows: At 10 am bio-
chemistry measurement is performed in the se-
rum sample with gel separator in the emergen-
cy laboratory. Upon measurement, samples are 
stored at room temperature without stoppers. 
Since the patient’s clinical symptoms are still un-
clear, ordering physician requests ethanol meas-
urement at 3 pm by phone. Please select re-
sponse which best describes laboratory proce-
dure with this sample.
Results, available answers and overall case score 
are presented in Table 8. The highest overall case 
score was recorded for this case (Cscore = 96). Nei-
ther laboratory chose the least desirable proce-
dure.Results, available answers and overall case score 
are presented in Table 7. The lowest overall case 
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Discussion
Overall, the first 2-year experience of preanalytical 
EQA of the Croatian Society of Medical Biochemis-
try and Laboratory Medicine and CROQALM show 
good compliance with recommended phleboto-
my procedures and good management in chal-
lenging preanalytical case studies. However, these 
results identify some unexpected weak spots in 
the preanalytical phase that could have detrimen-
tal effect on results in some laboratories.
In 2013, WGPA CSMBLM recognized a need for im-
plementing nationwide standard in phlebotomy 
and issued a document Croatian Society of Medi-
cal Biochemistry and Laboratory Medicine: nation-
al recommendations for venous blood sampling 
(7). Document was distributed to all members of 
the CSMBLM society free of charge and several ed-
ucational events were organized to assure imple-
mentation of the procedure. In 2014, EQA in pre-
analytical phase aimed to investigate compliance 
with the recommended procedure.
Several items scored very low in the section deal-
ing with materials and equipment. Sterile disposa-
ble tourniquets were present only in small propor-
tion of laboratories. In Croatia, most laboratories 
use reusable rubber or fabric tourniquets. Recent-
ly, a microbiological investigation of reusable tour-
niquets was conducted in University Hospital 
Center Sestre Milosrdnice (Zagreb, Croatia) (8). The 
results of this study show average tourniquet du-
ration of 165 (90–360) days. Only 17% of partici-
pants wash tourniquet daily and only 27% disin-
fect tourniquet daily. Microbiological analysis 
showed that some bacterial flora was detected on 
all but two tourniquets. Bacillus sp. were detected 
on 5/52, Enterococcus sp. on 2/52, Methicillin-resist-
ant Staphylococcus aureus (MRSA) on 2/52 and S. 
Case 5 N = 165 Points Max case points
Case 
points Cscore
1. CRP and glucose will be measured and reported in this sample without 
any comments 1 0
825 734 89
2. CRP and glucose will be measured and reported from the serum 
sample, an interpretative comment on influence of sampling time on 
glucose concentration will be added
24 3
3. The result for CRP will be reported, the result for glucose will be 
suppressed 102 5
4. The sample is inadequate, tests will not be measured in this sample 38 4
Table 7. Preanalytical cases in CROQALM EQA: results, available answers and overall case score for Case 5.
Case 6 N = 147 Points Max case points
Case 
points Cscore
1. The sample is unacceptable, the measurement of ethanol will not be 
done 135 5
735 708 96
2. Ethanol will be measured and result reported without any comments. 0 0
3. Ethanol will be measured, but the result will be reported without 
an interpretative comment on possible falsely decreased ethanol 
concentration
11 3
4. Ethanol will be measured only if the electronic or paper request is 
delivered to laboratory 1 0
Table 8. Preanalytical cases in CROQALM EQA: results, available answers and overall case score for Case 6.
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aureus on 1 out of 52 tested tourniquets. These re-
sults are in agreement with several other previous-
ly published studies (9,10). Elhassan HA and Dixon 
T have identified 18/50 tourniquets positive for S. 
aureus and 6/50 positive for MRSA (11). These re-
sults show that reusable tourniquets pose serious 
health risk, not only for patients, but also for the 
medical professionals. Laboratories are encour-
aged to use disposable tourniquets. 
The other important issue arisen from this section 
is low distribution of safe-sharp needles. Although 
being in effect for several years, The Directive 
2010/32/EU “Prevention from sharp injuries in the 
hospital and healthcare sector” (12) has not been 
implemented in Croatian laboratories. There is an 
ample of evidence that safe-sharp laboratory ma-
terials significantly lower risk of needle-stick inju-
ries (13). Even though the main reason for delaying 
implementation of safe-sharp equipment is in-
creased cost for the laboratory, the overall cost for 
the diagnostics and treatment of needle-stick inju-
ries for the healthcare in general is higher (14,15). 
Results of EQA detected no critical areas in the 
section dealing with patient identification. Isolat-
ed low Qscore for obtaining patients address only 
points to the non-standardized types of questions 
used for patient identification. The most reliable 
way of providing identification document is not 
widespread in Croatia. There is also a great varia-
bility in tube labelling. While almost perfect score 
(Qscore = 98) was obtained for the patient ID on 
the tube, other identifiers (patients name and pa-
tients date of birth) were present with the lower 
frequency. Nevertheless, Qscore for two identifiers 
present at each tube was rather high (Qscore = 86). 
Patient identification is the most crucial step in the 
phlebotomy process. In the recently published 
survey by the Working group for the preanalytical 
phase of the European Federation of Clinical 
Chemistry and Laboratory Medicine (EFLM WG-
PRE), patient identification and test tube labelling 
were identified as the key guideline issues with the 
highest combination of occurrence probability 
and potential risk of harm (16). Recognizing the im-
portance of this issue, EFLM WG-PRE issues a call 
for harmonization in patient identification and 
tube labelling (17). Since harmonization of this 
phase of the process is not yet achieved in Croa-
tian laboratories, overall good performance can 
certainly be improved by implementation of EFLM 
WG-PRE standards. 
Verification of patient preparation scored ex-
tremely well in the Croatian preanalytical EQA. 
However, only fasting status was presented in a 
preanalytical case and no other specific prepara-
tions were investigated here. Working Group for 
Patient Preparation of the Croatian Society of 
Medical Biochemistry and Laboratory Medicine 
(WGPP CSMBLM) recently published results of a 
survey on instructions for patient preparation in 
Croatian laboratories (18). Although results 
showed that instructions are not standardized and 
that the information is lacking for some specific ar-
eas like therapeutic drug monitoring, coagulation 
and endocrinology, instructions in the field of clin-
ical chemistry were rather uniform. This is proba-
bly a result of availability of patient preparation in-
structions in the field of clinical chemistry (19). The 
study discovered that adherence to existing guide-
lines is rather high, but where guidelines are lack-
ing, laboratories fail to issue their own guidelines 
(18). WGPP CSMBLM identified the need for the 
standardized evidence based guidelines for all ar-
eas of laboratory medicine. Adherence to the 
EFLM WG-PRE recommendation that patients 
should be fasting prior to phlebotomy and that 
phlebotomy should be postponed if the patients 
are not fasting was very high (20,21).
Phlebotomy technique seems to completely be 
adherent to the published national standards for 
venous blood sampling. All steps scored extreme-
ly high. The only area where potential for improve-
ment was detected was the repeated phlebotomy. 
Hence, when repeating unsuccessful phlebotomy, 
most laboratories use evacuated tubes, same as 
the initial phlebotomy. There is evidence that 
tubes using manual aspiration are more suitable in 
these situations because lower force reduces stress 
and the consequent injury of blood cells in com-
parison with the evacuated tubes and lowers the 
risk of hemolysis and prevents hyper-activation of 
platelets (22, 23). These tubes could, therefore, be 
better for repeated blood sampling. 
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Transportation and storage is also extremely im-
portant preanalytical requirement (24). Unfortu-
nately, some items scored very low in this area. An 
issue of glucose tube arose from this question-
naire. Very low score (QScore = 21) was recorded 
for exclusive usage of glycolysis inhibitor tubes for 
the glucose concentration measurement. It is well 
documented that glucose concentration decreas-
es over time in serum and plasma tubes without 
the inhibitor. Juricic et al. recently published an ar-
ticle comparing glucose concentration in four dif-
ferent types of tube: serum without additive, lithi-
um heparin plasma, sodium flouride/potassium 
oxalate (NaF/KOx) plasma and liquid citrate plas-
ma. They have found that if all tubes were centri-
fuged within 30 minutes and measurement done 
immediately, there is a statistically significant dif-
ference in glucose concentration. The highest 
drop of glucose concentration was observed in 
the serum tube, then in NaF/KOx followed by lithi-
um-heparin tube sampled on ice. Liquid citrate 
tube preserved glucose concentration the best 
(25). These results underline the risks associated 
with usage of serum tube for glucose concentra-
tion measurement: misdiagnosis of diabetes pa-
tients and falsely decreased glucose concentra-
tion. Even more relevant were the results of anoth-
er study by the same group of authors where the 
stability of glucose concentration in uncentrifuged 
tubes was investigated. These results clearly show 
that only the tube with liquid citrate can preserve 
glucose concentration in uncentrifuged tubes for 
the period of three hours (26). In Croatian primary 
care laboratories, sampling is done on phleboto-
my sites and general physician offices, samples 
collected and transported to larger hospital cen-
tres for processing (27). Since these areas are 
sometimes more than 100 km apart, several hours 
may pass from the sample collection to the glu-
cose concentration measurement. In these cases, 
it is necessary to introduce glycolysis inhibitor 
tube always when glucose concentration is or-
dered.
Many laboratories collect and store samples for 
the analyses that are rarely done. Samples are than 
analysed in batch in order to cut costs on calibra-
tion and control materials without compromising 
quality of results and patient safety. Almost all lab-
oratories declared (Qscore = 99) that they follow 
manufacturers declarations regarding tempera-
ture and time of storage. However, only small pro-
portion (Qscore = 31) has declared that they have 
verified those conditions. Manufacturers declara-
tions are often not confirmed in the routine labo-
ratory work (28,29). Recently we have published 
results of verification of storage conditions for an-
giotensin-converting enzyme (ACE kinetic, Bühl-
man Laboratories AG, Schonenbuch, Switzerland). 
Although the manufacturer has declared that the 
analyte is stable up to 6 months when frozen on - 
20 ⁰C, we have discovered that the decline in en-
zyme activity is unacceptable after 1 week (30). 
These results underline the need of each laborato-
ry to verify manufacturer’s declarations on analyte 
stability if samples are going to be stored prior to 
measurement.
Overall laboratory performance was very high in 
the preanalytical cases section, which confirms 
that laboratories are well educated and equipped 
to resolve complex preanalytical issues. The low-
est score was observed in the case dealing with 
sample stability for the glucose concentration 
measurement. While certain number of laborato-
ries saw nothing unacceptable in reporting the re-
sult for glucose concentration from the sample 
that has been drawn 5 hours before the admission 
to laboratory, another proportion turned down re-
porting result for the stable analyte (CRP). The in-
tention of laboratory should always be to report as 
many results as possible while maintaining quality 
of the measured result. If some parameters can’t 
be measured from the sample, sample should be 
partially analyzed in order to spare the patient of 
repeated sampling for all tests (smaller volume 
tubes can be sampled when sampling needs to be 
repeated).
Performance in the case dealing with haemolysed 
sample was rather high. Largest proportion of lab-
oratories does not report potassium concentration 
from the haemolysed sample, while smaller num-
ber report values with an interpretative com-
ments. A good knowledge of the proper detection 
and management of haemolysed, icteric and 
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lipemic samples has been documented in a re-
cently published work by the WGPA CSMBLM (31).
Our observations might have some limitations 
that are a direct result of the type of preanalytical 
EQA currently conducted in Croatia. Most of the 
detected problems were based on the self-report-
ed answers provided by the laboratory heads. It is 
possible that they were giving desirable answers 
rather than describing the real situation in their 
laboratories. An observational study carried out as 
an independent laboratory audit would give a 
better insight into problems in the preanalytical 
phase. Also, even though the response rate was 
very high, it was not complete and there were 
some variations between cycles. However, small 
number of laboratories that failed to participate in 
this EQA probably would not significantly change 
results.  
In conclusion, results of the first two years of pre-
analytical EQA CROQALM showed good compli-
ance with the national recommendations for phle-
botomy and excellent expertise in resolving com-
plex preanalytical issues. Some weak spots in pre-
analytical phase of Croatian laboratories are iden-
tified. Safe-sharp needles and disposable tourni-
quets which are necessary for reduced staff and 
patients risk during the phlebotomy procedure are 
not available in all laboratories. Additionally, 
standardization of glucose concentration meas-
urement regarding tube type and sample accept-
ance criteria should be implemented. Verification 
of manufacturer’s procedures is necessary when 
samples are stored. These issues will continue to 
be monitored in order to achieve highest stand-
ards of laboratory work. Croatian Society of Medi-
cal Biochemistry and Laboratory Medicine and 
CROQALM will continue their educational efforts 
to improve preanalytical phase in Croatian labora-
tories.
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